RBM24

Across TCGA pan-cancer cohorts, RBM24 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RBM24’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RBM24 RNA is repressed in tumor relative to normal tissue. In most cancer types RBM24 is over-expressed in tumor, although a few such as BLCA and THCA show the opposite, repressed pattern.

BLCA, THCA, and LIHC are the cancer types where RBM24 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM24 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	IV	−3.612	<.001	11	view →
THCA	Male	IV	−2.046	<.001	11	view →
LIHC	Male	II,III,IV	+2.147	<.001	8	view →
KICH	Female	All	−1.336	<.001	8	view →
COAD	Male	All	−1.196	<.001	8	view →
KIRC	Male	All	+1.007	<.001	8	view →
READ	Female	All	−2.738	<.001	7	view →
LUAD	Female	III,IV	−0.883	<.001	7	view →
UCEC	All	All	−2.658	<.001	6	view →
LUSC	Female	All	−0.761	<.001	5	view →
STAD	All	All	−0.971	.005	3	view →
CHOL	Male	All	+1.633	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RBM24–BLCA

Open the BLCA breakdown →